InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Explore the full record of transactions filed by Jimenez Freddy A., SVP & Conseiller Juridique. Director active across 1 companies, notably Celldex Therapeutics, Inc.. In total, 2 filings have been recorded. Total volume traded: €34k. The latest transaction was filed on 11 August 2021 (Acquisition). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations2 total
€16,948430 shares@ €39.41440.0007% mcap100.0% of flow
Common Stock
SEC:0001179110-21-008163·
Ideal exit: 8 May 2022 (T+270)
€16,948430 shares@ €39.41440.0007% mcap50.0% of flow
Common Stock
SEC:0001179110-21-008163:0·
Ideal exit: 8 May 2022 (T+270)
2 of 2 declarations
About Jimenez Freddy A.
Freddy A. Jimenez is the Senior Vice President and General Counsel of Celldex Therapeutics, Inc. He oversees the legal affairs of the company, ensuring regulatory compliance and protecting the legal interests of Celldex. His expertise in business law is essential for navigating the complex legal landscape of the industry.
